AstraZeneca Aims for Wider Heart Prevention With Diabetes Drug

(Bloomberg) -- AstraZeneca Plc is aiming for wider use of its Farxiga diabetes drug as a study showed that it staved off lethal heart disease in a broad variety of patients.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.